UCLE: US Nuclear Corp. Stock

SIC 3829 – Measuring and Controlling Devices, Not Elsewhere Classified

Valuation
Market Cap ($M) 4.62
Enterprise Value ($M) 6.52
Book Value ($M) -0.15
Book Value / Share -0.00
Price / Book -31.76
NCAV ($M) -0.72
NCAV / Share -0.01
Price / NCAV -6.40

Profitability (mra)
Return on Invested Capital (ROIC) -1.05
Return on Assets (ROA) -0.65
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.22
Current Ratio 1.04

Balance Sheet (mrq) ($M)
Current Assets 2.51
Assets 3.08
Liabilities 3.23
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-27 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended SEPTEMBER 30, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(
2024-10-04 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended JUNE 30, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF
2024-08-01 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended MARCH 31, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) O
2024-05-10 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT UNDER SECTIO

(click for more detail)

Similar Companies
TLIS – Talis Biomedical Corporation TMRNF – Tamron Co.,Ltd.
TRCC – Traccom Inc. WELX – Winland Holdings Corporation


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.